Associated Papers
Discriminating activating, deactivating and resistance variants in protein kinases.
Singh G et al.
Genome Medicine, 2025
Theorizing The Role of Gama Type Endorphins in Schizophrenia and Alcoholism: Promoting Genetic Testing and Attempts at Inducing "Dopamine Homeostasis".
Blum K et al.
Acta Scientific Neurology, 2025
Investigating the impact of polymorphisms in the ANKK1 and DRD2 genes on oral health-related quality of life in male patients with temporomandibular disorders.
Baratto SSP et al.
Frontiers in Oral Health, 2025
Dopamine D2 receptor gene Taq 1A polymorphism: genetic architecture in Indian population and comparison to global populations.
Chaudhary A et al.
Frontiers in Genetics, 2025
ANKK1 Is a Wnt/PCP Scaffold Protein for Neural F-ACTIN Assembly.
Domínguez-Berzosa L et al.
International Journal of Molecular Sciences, 2024
The polymorphisms of candidate pharmacokinetic and pharmacodynamic genes and their pharmacogenetic impacts on the effectiveness of risperidone maintenance therapy among Saudi children with autism.
Shilbayeh SAR et al.
European Journal of Clinical Pharmacology, 2024
Association between dopamine receptor D2 Taq IA gene polymorphism (rs1800497) and personality traits.
Olasore HSA et al.
Sage Open Medicine, 2024
Evidence for the DRD2 Gene as a Determinant of Reward Deficiency Syndrome (RDS).
Blum K et al.
Clinical and Experimental Psychology, 2023
Decoding the genetic relationship between Alzheimer's disease and type 2 diabetes: potential risk variants and future direction for North Africa.
Boukhalfa W et al.
Frontiers in Aging Neuroscience, 2023
Athletic performance, sports experience, and exercise addiction: an association study on ANKK1 gene polymorphism rs1800497.
Bayraktar I et al.
Frontiers in Psychology, 2023
"TO BE OR NOT TO BE" GWAS Ends the Controversy about the DRD2 Gene as a Determinant of Reward Deficiency Syndrome (RDS).
Blum K et al.
Psychology Research and Behavior Management, 2023
Expanding the prostate cancer cell line repertoire with ACRJ-PC28, an AR-negative neuroendocrine cell line derived from an African-Caribbean patient.
Valentine H et al.
Cancer Research Communications, 2022
Translational Genomic Research: The Association between Genetic Profiles and Cognitive Functioning or Cardiac Function Among Breast Cancer Survivors Completing Chemotherapy.
Park JY et al.
Biological Research for Nursing, 2022
Genomic, transcriptomic, and metabolomic profiles of hiPSC-derived dopamine neurons from clinically discordant brothers with identical PRKN deletions.
Cukier HN et al.
Npj Parkinson's Disease, 2022
Sequence and Structure-Based Analyses of Human Ankyrin Repeats.
Chakrabarty B et al.
Molecules (basel, Switzerland), 2022
Ankk1 Loss of Function Disrupts Dopaminergic Pathways in Zebrafish.
Leggieri A et al.
Frontiers in Neuroscience, 2022
The Role of Dopaminergic Genes in Probabilistic Reinforcement Learning in Schizophrenia Spectrum Disorders.
Frydecka D et al.
Brain Sciences, 2021
Genetic Influences on Patient-Oriented Outcomes in Traumatic Brain Injury: A Living Systematic Review of Non-Apolipoprotein E Single-Nucleotide Polymorphisms.
Zeiler FA et al.
Journal of Neurotrauma, 2021
Weight-loss response to naltrexone/bupropion is modulated by the Taq1A genetic variant near DRD2 (rs1800497): A pilot study.
Mullally JA et al.
Diabetes, Obesity & Metabolism, 2021
Investigating the association between common DRD2/ANKK1 genetic polymorphisms and schizophrenia: a meta-analysis.
Habibzadeh P et al.
Journal of Genetics, 2021
Ankyrin Repeat and Kinase Domain Containing 1 Gene, and Addiction Vulnerability.
Koeneke A et al.
International Journal of Molecular Sciences, 2020
Workflow for the Implementation of Precision Genomics in Healthcare.
Mehandziska S et al.
Frontiers in Genetics, 2020
Translational genomic research: the role of genetic polymorphisms in MBSR program among breast cancer survivors (MBSR[BC]).
Park JY et al.
Translational Behavioral Medicine, 2019
Genetic analysis of pharmacogenomic VIP variants in the Blang population from Yunnan Province of China.
Zhang C et al.
Molecular Genetics & Genomic Medicine, 2019
CALCA and TRPV1 genes polymorphisms are related to a good outcome in female chronic migraine patients treated with OnabotulinumtoxinA.
Moreno-Mayordomo R et al.
The Journal of Headache and Pain, 2019
Actionable Pharmacogenetic Variation in the Slovenian Genomic Database.
Hočevar K et al.
Frontiers in Pharmacology, 2019
Assessment of coding region variants in Kuwaiti population: implications for medical genetics and population genomics.
John SE et al.
Scientific Reports, 2018
Relations between early maternal sensitivity and toddler self-regulation: Exploring variation by oxytocin and dopamine D2 receptor genes.
Augustine ME et al.
Developmental Psychobiology, 2018
A neurobiological pathway to smoking in adolescence: TTC12-ANKK1-DRD2 variants and reward response.
Macare C et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology, 2018
Genetic influence alters the brain synchronism in perception and timing.
Marinho V et al.
Journal of Biomedical Science, 2018
Arylsulphatase A Pseudodeficiency (ARSA-PD), hypertension and chronic renal disease in Aboriginal Australians.
Tang D et al.
Scientific Reports, 2018
DRD2/ANKK1 gene polymorphisms in forensic autopsies of methamphetamine intoxication fatalities.
Matsusue A et al.
Legal Medicine (tokyo, Japan), 2018
Sources of discordance among germ-line variant classifications in ClinVar.
Yang S et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2017
Exploring genetic influences underlying acute aerobic exercise effects on motor learning.
Mang CS et al.
Scientific Reports, 2017
Effect of single-nucleotide polymorphisms in ADH1B, ADH4, ADH1C, OPRM1, DRD2, BDNF, and ALDH2 genes on alcohol dependence in a Caucasian population.
Katsarou MS et al.
Pharmacology Research & Perspectives, 2017
Identification of rs7350481 at chromosome 11q23.3 as a novel susceptibility locus for metabolic syndrome in Japanese individuals by an exome-wide association study.
Yamada Y et al.
Oncotarget, 2017
Investigation of DNA repair-related SNPs underlying susceptibility to papillary thyroid carcinoma reveals MGMT as a novel candidate gene in Belarusian children exposed to radiation.
Lonjou C et al.
Bmc Cancer, 2017
High frequency of the DRD2/ANKK1 A1 allele in Mexican Native Amerindians and Mestizos and its association with alcohol consumption.
Panduro A et al.
Drug and Alcohol Dependence, 2017
Assessing the capability of massively parallel sequencing for opportunistic pharmacogenetic screening.
Ng D et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2017
Impact of DRD2/ANKK1 and COMT Polymorphisms on Attention and Cognitive Functions in Schizophrenia.
Nkam I et al.
Plos One, 2017
Uncovering precision phenotype-biomarker associations in traumatic brain injury using topological data analysis.
Nielson JL et al.
Plos One, 2017
Genetically-Driven Enhancement of Dopaminergic Transmission Affects Moral Acceptability in Females but Not in Males: A Pilot Study.
Pellegrini S et al.
Frontiers in Behavioral Neuroscience, 2017
Pharmacogenetic tests for antipsychotic medications: clinical implications and considerations.
Eum S et al.
Dialogues in Clinical Neuroscience, 2016
Genetic polymorphisms of pharmacogenomic VIP variants in the Mongol of Northwestern China.
Jin T et al.
Bmc Genetics, 2016
A Prospective Cohort Study of Influences on Externalizing Behaviors Across Childhood: Results From a Nurse Home Visiting Randomized Controlled Trial.
Enoch MA et al.
Journal of the American Academy of Child and Adolescent Psychiatry, 2016
Genetic variation and dopamine D2 receptor availability: a systematic review and meta-analysis of human in vivo molecular imaging studies.
Gluskin BS et al.
Translational Psychiatry, 2016
The population genetics of pharmacogenomics VIP variants in the Sherpa population.
Wang L et al.
Drug Metabolism and Pharmacokinetics, 2016
The Association of DRD2 with Insight Problem Solving.
Zhang S et al.
Frontiers in Psychology, 2016
The ANKK1/DRD2 locus is a genomic substrate for affective priming and recognition of angry faces.
Koeneke A et al.
Brain and Behavior, 2015